A roundup of several recent Michigan Medicine discoveries that are shedding new light on pediatric brain cancers and helping to improve treatment options.

A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.

Anti-androgen therapy showed positive results in cell lines and animal models.

A Rogel Cancer Center team created a guide to help providers navigate difficult conversations due to the coronavirus.

Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.

Multi-institution analysis identifies a new chromosomal abnormality linked to enzalutamide resistance.